Dioseve
Company

Last deal

$7.M

Amount

Venture - Series Unknown

Stage

27.06.2024

Date

2

all rounds

$10.M

Total amount

General

About Company
Dioseve develops technologies to create fertilizable eggs from iPS cells / ES cells, providing novel possibilities for all life.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2021

Number of employees

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's mission is to establish unprecedented infertility treatment by providing oocytes for couples who cannot give birth. Dioseve's innovative approach involves developing technologies to create fertilizable eggs from iPS cells / ES cells. By doing so, they hope to offer a new solution to infertility that could change the lives of millions of people.
Contacts

location

Social url